Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Brian........Can we?

Gain operational and licensing control over the MMP?? How do we take that away from TPL?

"should we gain operational and licensing control of the MMP portfolio. Stockholder value and desirability will only be enhanced."

Share
New Message
Please login to post a reply